Global Biotech API Market Analysis by bharatbookseo


More Info
									Bharat Book introduces a report " Global Biotech API Market Analysis " Biotech APIs
contribute a very low share in the global API market with synthetic API’s accounting for
majority of the formulations. However, with the revolutionary growth in the biopharmaceutical
industry and gaining applications of biotech drugs, biotech API’s are sure to see a highly
prospective market in the future.

As per our report, “Global Biotech API Market Analysis”, the focus of global pharmaceutical
and biotech industry participants is shifting towards cost-effective and quality-driven
destinations, such as India and China. These countries provide cheap labor, high productivity,
low-investment to set-up plant, and good profit margins, among others. In addition, there is a set
of regulations that support the local manufacturing and encourage export between nations.

The report also provides an in-depth profiling of the major companies involved in the biotech
API business to gain insights on their overall business, biotech API functioning, recent activities
and an analysis on their strengths and weaknesses. Prudent market segmentation and forecasts
have been provided to help players in the industry take informed decisions based on the future
dynamics of this market. The geographic analysis and regulatory overview provide a holistic
understanding to the reader to tap the potential opportunity areas in this industry. Business

Table of Contents:
1. Analyst View
2. Research Methodology
3. Biotech Active Pharmaceutical Ingredients - An Introduction
4. Active Pharmaceutical Ingredient - Industry Performance
4.1 Current and Future Market Analysis to 2015
4.2 Branded and Generic APIs
4.3 Synthetic and Biotech APIs
5. Biotech Active Pharmaceutical Ingredients - Industry Performance
5.1 Current and Future Market Analysis to 2015
5.2 Biogeneric and Innovator Biotech APIs
5.3 Key Geographical Markets
6. Regulatory Environment
7. Competitive Landscape
7.1 Bayer Pharma AG
7.1.1 Business Overview
7.1.2 Strengths and Weaknesses
7.1.3 Recent Developments
7.2 Biocon Limited
7.2.1 Business Overview
7.2.2 Strengths and Weaknesses
7.2.3 Recent Developments
7.3 Boehringer Ingelheim
7.3.1 Business Overview
7.3.2 Strengths and Weaknesses
7.3.3 Recent Developments
7.4 Hospira
7.4.1 Business Overview
7.4.2 Strengths and Weaknesses
7.4.3 Recent Developments
7.5 Lonza
7.5.1 Business Overview
7.5.2 Strengths and Weaknesses
7.5.3 Recent Developments
7.6 Ranbaxy Laboratories
7.6.1 Business Overview
7.6.2 Strengths and Weaknesses
7.6.3 Recent Developments
7.7 Royal Dsm N.V.
7.7.1 Business Description
7.7.2 Strengths and Weaknesses
7.7.3 Recent Developments
7.8 Sigma-Aldrich
7.8.1 Business Overview
7.8.2 Strengths and Weaknesses
7.8.3 Recent Developments
7.9 Teva Active Pharmaceutical Ingredients
7.9.1 Business Overview
7.9.2 Strengths and Weaknesses
7.9.3 Recent Developments
7.10 Zhejiang Hisun Pharmaceutical Co. Ltd.
7.10.1 Business Overview
7.10.2 Strengths and Weaknesses
7.10.3 Recent Developments

List of Figures:
Figure 4-1: Global - API Market (Billion US$), 2011-2015
Figure 4-2: Global - Share of Captive and Merchant Market in API Market (2011)
Figure 4-3: Global - Share of Branded and Generic APIs in API Merchant Market (2011)
Figure 4-4: Global - Share of Synthetic and Biotech APIs in API Market (2011)
Figure 5-1: Global - Biotech API Market (Billion US$), 2011-2015
Figure 5-2: Global - Share of Biogeneric and Innovator APIs in Biotech API Market by (2011)
Figure 5-3: Global - Biotech API Market by Country (%), 2011

For more information kindly visit :
Insulin Market Forecast to 2015

Bharat Book Bureau
Tel: +91 22 27810772 / 27810773
Fax: + 91 22 27812290
Follow us on twitter:!/Sandhya3B
Our Blogs:

To top